VHH-based chimeric antigen receptor T cells against CD70 to eliminate primary and rechallenge renal cell carcinoma tumors in preclinical study.

被引：0
|
作者：
Jiang, Pengfei [1 ]
Xiong, Qinghui [1 ]
Wang, Haiying [1 ]
Deng, Tian [1 ]
机构：
[1] HRAIN Biotechnol, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14540
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia
    Kenderian, S. S.
    Ruella, M.
    Shestova, O.
    Klichinsky, M.
    Aikawa, V.
    Morrissette, J. J. D.
    Scholler, J.
    Song, D.
    Porter, D. L.
    Carroll, M.
    June, C. H.
    Gill, S.
    LEUKEMIA, 2015, 29 (08) : 1637 - 1647
  • [22] T cell receptor gene-modified T cells with specificity against a broadly expressed renal cell carcinoma antigen
    Leisegang, Matthias
    Turqueti, Adriana
    Blankenstein, Thomas
    Schendel, Dolores
    Noessner, Elfriede
    Uckert, Wolfgang
    HUMAN GENE THERAPY, 2008, 19 (10) : 1137 - 1137
  • [23] Trispecific CD19-CD20-CD22-targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models
    Schneider, Dina
    Xiong, Ying
    Wu, Darong
    Hu, Peirong
    Alabanza, Leah
    Steimle, Brittany
    Mahmud, Hasan
    Anthony-Gonda, Kim
    Krueger, Winfried
    Zhu, Zhongyu
    Dimitrov, Dimiter S.
    Orentas, Rimas J.
    Dropulic, Boro
    SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (586)
  • [24] TCRvβ8 chimeric antigen receptor natural killer cells exhibit potent preclinical activity against T-cell malignancies
    He, Lianjun
    He, Yinmei
    He, Ye
    Bao, Xing
    Yang, Yuqiong
    Qian, Xueyi
    Lin, Ziyun
    He, Weijie
    Wu, Yao
    Shao, Huimin
    Zhou, Lingjie
    Wan, Lin
    Xu, Zhenyu
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (08):
  • [25] Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells
    K Pinz
    H Liu
    M Golightly
    A Jares
    F Lan
    G W Zieve
    N Hagag
    M Schuster
    A E Firor
    X Jiang
    Y Ma
    Leukemia, 2016, 30 : 701 - 707
  • [26] Preclinical targeting of human T-cell malignancies using CD4-specific chimeric antigen receptor (CAR)-engineered T cells
    Pinz, K.
    Liu, H.
    Golightly, M.
    Jares, A.
    Lan, F.
    Zieve, G. W.
    Hagag, N.
    Schuster, M.
    Firor, A. E.
    Jiang, X.
    Ma, Y.
    LEUKEMIA, 2016, 30 (03) : 701 - 707
  • [27] NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
    Parihar, Robin
    Rivas, Charlotte
    Mai Huynh
    Omer, Bilal
    Lapteva, Natalia
    Metelitsa, Leonid S.
    Gottschalk, Stephen M.
    Rooney, Cliona M.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (03) : 363 - 375
  • [28] NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma
    Murayama, Yudai
    Kasahara, Yasushi
    Kubo, Nobuhiro
    Shin, Chansu
    Imamura, Masaru
    Oike, Naoki
    Ariizumi, Takashi
    Saitoh, Akihiko
    Baba, Minori
    Miyazaki, Tomohiro
    Suzuki, Yuko
    Ling, Yiwei
    Okuda, Shujiro
    Mihara, Keichiro
    Ogose, Akira
    Kawashima, Hiroyuki
    Imai, Chihaya
    TRANSLATIONAL ONCOLOGY, 2022, 25
  • [29] Targeting T-cell Leukemia with CD5-Based Chimeric Antigen Receptor-Modified γδ T Cells
    Fleischer, Lauren C.
    Zoine, Jaquelyn T.
    Ryan, Rebecca E.
    Raikar, Sunil S.
    Doering, Christopher B.
    Spencer, H. Trent
    MOLECULAR THERAPY, 2018, 26 (05) : 57 - 57
  • [30] A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
    Torikai, Hiroki
    Reik, Andreas
    Liu, Pei-Qi
    Zhou, Yuanyue
    Zhang, Ling
    Maiti, Sourindra
    Huls, Helen
    Miller, Jeffrey C.
    Kebriaei, Partow
    Rabinovitch, Brian
    Lee, Dean A.
    Champlin, Richard E.
    Bonini, Chiara
    Naldini, Luigi
    Rebar, Edward J.
    Gregory, Philip D.
    Holmes, Michael C.
    Cooper, Laurence J. N.
    BLOOD, 2012, 119 (24) : 5697 - 5705
12345